Company profile for Chiasma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are passionate about our purpose, we are committed to each other and we act as one team with a heightened sense of urgency. Situated in the biotech hub of Massachusetts, our corporate headquarters is located in Needham, MA, a suburb of Boston/Cambridge. We employ high-energy team players who are both passionate about their work and compassionate for the patients we serve. We are looking for innovative thinkers who enjoy r...
We are passionate about our purpose, we are committed to each other and we act as one team with a heightened sense of urgency. Situated in the biotech hub of Massachusetts, our corporate headquarters is located in Needham, MA, a suburb of Boston/Cambridge. We employ high-energy team players who are both passionate about their work and compassionate for the patients we serve. We are looking for innovative thinkers who enjoy rolling up their sleeves, thrive within a fast-moving environment and conduct themselves with the utmost integrity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
140 Kendrick Street Building C East Needham, MA 02494
Telephone
Telephone
844.304.2462
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/ex-novartis-pituitary-senior-medical-director-chiasma-svp-jumps-to-recordati-rare-disease

FIERCEBIOTECH
25 Aug 2021

https://www.globenewswire.com/news-release/2021/06/28/2254272/0/en/Chiasma-Announces-Submission-of-Marketing-Authorization-Application-for-MYCAPSSA-to-the-European-Medicines-Agency.html

GLOBENEWSWIRE
28 Jun 2021

https://www.globenewswire.com/news-release/2021/06/15/2247089/0/en/Amryt-Pharma-Announces-Filing-of-Preliminary-Registration-Statement-on-Form-F-4-in-Connection-with-Its-Proposed-Acquisition-of-Chiasma-Inc.html

GLOBENEWSWIRE
15 Jun 2021

https://www.globenewswire.com/fr/news-release/2021/05/20/2233291/0/en/Chiasma-to-Present-Encore-and-New-Data-from-MPOWERED-Phase-3-Trial-at-Upcoming-e-ECE-and-AACE-Virtual-Conferences.html

GLOBENEWSWIRE
27 May 2021

https://www.globenewswire.com/news-release/2021/05/20/2233291/0/en/Chiasma-to-Present-Encore-and-New-Data-from-MPOWERED-Phase-3-Trial-at-Upcoming-e-ECE-and-AACE-Virtual-Conferences.html

GLOBENEWSWIRE
20 May 2021

https://www.globenewswire.com/news-release/2021/03/20/2196502/0/en/Chiasma-Presents-New-Positive-Data-for-MYCAPSSA-from-Phase-3-Trial-MPOWERED-for-the-Maintenance-Treatment-of-Acromegaly-at-ENDO-2021.html

GLOBENEWSWIRE
23 Mar 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty